BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15717634)

  • 1. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonsillectomy does not prevent a progressive course in IgA nephropathy.
    Rasche FM; Schwarz A; Keller F
    Clin Nephrol; 1999 Mar; 51(3):147-52. PubMed ID: 10099887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
    Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y
    Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Fukuda A; Fukudome K; Yamada K; Sato Y; Kitamura K
    Am J Nephrol; 2009; 30(1):19-25. PubMed ID: 19169006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.
    Piccoli A; Codognotto M; Tabbi MG; Favaro E; Rossi B
    Nephrol Dial Transplant; 2010 Aug; 25(8):2583-9. PubMed ID: 20200005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T; Fernando ME; Jayakumar M
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cumulative renal survival analysis of 495 cases of IgA nephropathy].
    Qin Y; Li XW; Li H; Duan L; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):160-3. PubMed ID: 15171553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
    Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
    Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.